Stichworte
Koronarkrankheit ×
Behandlungsbedürftigkeit, Begutachtung ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

60 Suchergebnisse.

Sortieren (Relevanz) ▾

Eligibility Coronary Heart Disease NCT01654653

- 04.02.18 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01654653

Eligibility Coronary Heart Disease NCT01021930

- 04.02.18 - 1 Formular, 2 Itemgruppen, 21 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT; ODM derived from: https://clinicaltrials.gov/show/NCT01021930

Eligibility Coronary Heart Disease NCT00959972

- 04.02.18 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00959972

Eligibility Coronary Heart Disease NCT00950339

- 04.02.18 - 1 Formular, 2 Itemgruppen, 15 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine; ODM derived from: https://clinicaltrials.gov/show/NCT00950339

Eligibility Coronary Heart Disease NCT00939237

- 03.02.18 - 1 Formular, 2 Itemgruppen, 17 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00939237

Eligibility Coronary Heart Disease NCT00924391

- 03.02.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Efficacy of Sterol Enhanced Soy Beverage on Cholesterol Metabolism, Inflammation and Oxidative Status in Humans; ODM derived from: https://clinicaltrials.gov/show/NCT00924391

Eligibility Coronary Heart Disease NCT00907998

- 03.02.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180; ODM derived from: https://clinicaltrials.gov/show/NCT00907998

Eligibility Coronary Heart Disease NCT00817024

- 03.02.18 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD); ODM derived from: https://clinicaltrials.gov/show/NCT00817024

Eligibility Coronary Heart Disease NCT00795405

- 03.02.18 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Cardiovascular Effects of Sporting Events; ODM derived from: https://clinicaltrials.gov/show/NCT00795405

Eligibility Coronary Heart Disease NCT00724542

- 03.02.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.; ODM derived from: https://clinicaltrials.gov/show/NCT00724542

Eligibility Coronary Heart Disease NCT00655473

- 02.02.18 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00655473

Eligibility Coronary Heart Disease NCT00598533

- 02.02.18 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis; ODM derived from: https://clinicaltrials.gov/show/NCT00598533